It has also been shown that ketamine has anti-inflammatory properties that might contribute to its antidepressant effects (Yang et al., 2015), e.g., in patients with treatment resistant depression, serum IL6 concentrations were decreased only in patients who responded to ketamine therapy (Yang et al., 2015). This evidence concerns the gene IL6 and depressive disorder.